Windtree Therapeutics, Inc.
WINT
$0.05
$0.00-5.74%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -164.18% | -162.82% | -246.19% | 200.65% | 77.14% |
| Total Depreciation and Amortization | 2,017.65% | 0.00% | 104.49% | -1,904.76% | -12.50% |
| Total Amortization of Deferred Charges | -196.41% | -- | -- | 273.08% | -56.67% |
| Total Other Non-Cash Items | 256.11% | 5,246.92% | 101.86% | -396.37% | -117.78% |
| Change in Net Operating Assets | -334.97% | -19.45% | 84.30% | 134.63% | -236.77% |
| Cash from Operations | -139.82% | -10.39% | 34.68% | 42.82% | -177.04% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 84.78% | -- | -- | -- | -- |
| Cash from Investing | 84.78% | -- | -- | -- | 100.00% |
| Total Debt Issued | -137.60% | 2,818.40% | -- | -100.00% | -87.97% |
| Total Debt Repaid | -196.48% | -362.05% | -49.55% | 75.92% | -- |
| Issuance of Common Stock | 2,961.82% | -80.79% | -50.37% | -44.38% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | 100.00% | 53.06% | -21.49% | -- |
| Total Dividends Paid | -- | 100.00% | 70.97% | 10.66% | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | 247.06% |
| Cash from Financing | 1.35% | 286.95% | -43.08% | -54.42% | 335.45% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 88.86% | -43.73% | -16.31% | -204.83% | 166.80% |